These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35143496)

  • 1. Research on government subsidy strategies for new drug R&D considering spillover effects.
    Huang Z; Lan Y; Zha X
    PLoS One; 2022; 17(2):e0262655. PubMed ID: 35143496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on green decision making of pharmaceutical logistics considering government subsidy strategy.
    Huang Z; Fu M
    PLoS One; 2020; 15(10):e0241400. PubMed ID: 33125413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coping with drug shortages: A study of government-enterprise option cooperation stockpiling strategies for drugs in shortage considering API surrogate stockpiling subsidies.
    Lan Y; Meng C; Sun L; Huang Z
    PLoS One; 2024; 19(7):e0305383. PubMed ID: 38954737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Competing Photovoltaic Supply Chains: A Social Welfare Maximization Perspective.
    Chen Z; Su SI
    Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29156653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The government subsidy design considering the reference price effect in a green supply chain.
    Huang S; Du B; Chen Z; Cheng J
    Environ Sci Pollut Res Int; 2024 Mar; 31(15):22645-22662. PubMed ID: 38409384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Enterprises' R&D Innovation Cooperation Moran Strategy When Considering Tax Incentives.
    Xu Y; Zhu L
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China.
    Li J; Zhang X; Wang R; Cao K; Wan L; Ren X; Ding J; Li W
    Front Public Health; 2024; 12():1402581. PubMed ID: 39011324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supply chain decision based on green investment subsidy and risk aversion.
    Liu P; Yu S; Lin Z
    PLoS One; 2023; 18(11):e0293924. PubMed ID: 37931002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of different government subsidies on total-factor productivity: Evidence from private listed manufacturing enterprises in China.
    Wang D; Sun Y
    PLoS One; 2022; 17(1):e0263018. PubMed ID: 35100316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green closed-loop supply chain optimization strategy considering CER and incentive-compatibility theory under uncertainty.
    Guo J; Wang G; Gen M
    Math Biosci Eng; 2022 Jun; 19(9):9520-9549. PubMed ID: 35942771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How innovation funding leads enterprises to engage in research and development: Small and medium enterprises' perspective.
    Sun H; Yang X; Tang X; Peng F
    PLoS One; 2023; 18(7):e0289166. PubMed ID: 37490503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripartite Evolutionary Game Analysis of Financial Support for Science-Tech Enterprises' Innovation with Government Participation.
    Liu W; Liu Y; Gu J; Zhao J; Zhang R
    Comput Intell Neurosci; 2022; 2022():5207003. PubMed ID: 35535184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green credit policy, government subsidy, and enterprises "shifting from virtual to real".
    Tang Y; Wang L; Peng S
    Environ Sci Pollut Res Int; 2024 Jan; 31(3):3976-3994. PubMed ID: 38093076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparty Evolutionary Game Strategy for Green Technology Innovation Under Market Orientation and Pandemics.
    Gong M; Dai A
    Front Public Health; 2021; 9():821172. PubMed ID: 35145949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pricing and assembly rate decisions for a prefabricated construction supply chain under subsidy policies.
    Jiang W; Qi X
    PLoS One; 2022; 17(1):e0261896. PubMed ID: 34990462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of asymmetric medical insurance subsidy on hospitals competition under non-price regulation.
    Wang C; Nie PY
    Int J Equity Health; 2016 Nov; 15(1):184. PubMed ID: 27846902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of centralized band purchasing of pharmaceuticals on innovation of Chinese pharmaceutical firms: an empirical study based on double difference models.
    Chen X; Chen S; Wu Z; Wang S; Chen Y
    Front Public Health; 2024; 12():1406254. PubMed ID: 39035183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of government subsidy and weather on environmentally sustainable investment decision for agricultural supply chain.
    Fu H; Zhou T; Zhang S; Wang Q
    PLoS One; 2023; 18(5):e0285891. PubMed ID: 37200283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical enterprises drug quality strategy
    Xu Y; Zhu L
    Front Public Health; 2022; 10():1079232. PubMed ID: 36733287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deal or no deal on water-saving program? Exploring the optimal interval for government subsidies and internal incentives.
    Chen Z; Cheung KCK
    Water Environ Res; 2021 Feb; 93(2):274-305. PubMed ID: 33118679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.